根据最终合并协议,Viewpoint的每一股已发行和流通股份将转换为获得Isoray 3.3212股的权利。Viewpoint股东将拥有Isoray完全稀释的流通股49%的股份。
$华海药业(SH600521)$ $华东医药(SZ000963...查看全文
$ISORAY INC(ISR)$ CT ORDER - Confidential treatment order Filed: 2016-04-20 AccNo: 9999999997-16-022373 Size: 13 KB 网页链接
$ISORAY INC(ISR)$ 8-K - Current report Filed: 2016-04-12 AccNo: 0001144204-16-093915 Size: 14 KBItem 1.02: Termination of a Material Definitive Agreement 网页链接
$ISORAY INC(ISR)$ 内部交易: 2016-03-17,CEO,LAVOY THOMAS C ,买入,13294普通股, $0.90
$ISORAY INC(ISR)$ 内部交易: 2016-03-11,CEO,LAVOY THOMAS C ,买入,36706普通股, $0.89
$ISORAY INC(ISR)$ 内部交易: 2016-03-08,Director,McCormick Michael W ,买入,22000普通股, $0.87
$ISORAY INC(ISR)$ 8-K - Current report Filed: 2016-03-03 AccNo: 0001144204-16-085838 Size: 16 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$ISORAY INC(ISR)$ 8-K - Current report Filed: 2016-02-19 AccNo: 0001144204-16-083466 Size: 111 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Financial St...
$ISORAY INC(ISR)$ CT ORDER - Confidential treatment order Filed: 2016-02-11 AccNo: 9999999997-16-016705 Size: 13 KB 网页链接
$ISORAY INC(ISR)$ 8-K - Current report Filed: 2016-02-10 AccNo: 0001144204-16-080172 Size: 86 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$ISORAY INC(ISR)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-02-09 AccNo: 0001144204-16-080050 Size: 3 MB 网页链接